Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
305
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
-9.9M
-
Total reported value, excl. options
-
$7.21B
-
Value change
-
-$761M
-
Put/Call ratio
-
4.88
-
Number of buys
-
150
-
Number of sells
-
-134
-
Price
-
$78.18
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q3 2022
333 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q3 2022.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 305 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
of 92.4M outstanding shares and own 99.73% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (9.73M shares), VANGUARD GROUP INC (8.76M shares), BlackRock Inc. (7.73M shares), DIMENSIONAL FUND ADVISORS LP (4.85M shares), WELLINGTON MANAGEMENT GROUP LLP (4.44M shares), JPMORGAN CHASE & CO (4.05M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.71M shares), Invesco Ltd. (3.3M shares), VIKING GLOBAL INVESTORS LP (2.96M shares), and STATE STREET CORP (2.45M shares).
This table shows the top 305 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.